Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...

Insulin: Biosynthesis, Chemistry, and Preparation

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DietAI24 as a framework for comprehensive nutrition estimation using multimodal large language models.

Communications medicine·2025

Same author

Connected Insulin Pens and Pen Caps: Expanding Diabetes Technology Access and Adoption.

Diabetes spectrum : a publication of the American Diabetes Association·2025

Same author

A Review of Precision Insulin Management With Smart Insulin Pens: Opening Up the Digital Door to People on Insulin Injection Therapy.

Journal of diabetes science and technology·2022

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 11, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Building a Data-Driven Multiple Daily Insulin Therapy Model Using Smart Insulin Pens.

Rocio Harbison¹, Michele Hecht¹, Janice MacLeod²

¹Advanced Endocrinology and Diabetes Clinic, Houston, TX, USA.

Journal of Diabetes Science and Technology

|August 25, 2020

Summary

Connected devices like smart insulin pens offer a new way to manage diabetes remotely. This approach enables data-driven care models and virtual support for patients receiving injection therapy.

Keywords:

connected health data-driven digital health multiple daily insulin therapy numeracy smart insulin pen therapeutic inertia value-based care

More Related Videos

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

Related Experiment Videos

Last Updated: Dec 11, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

Area of Science:

Digital Health
Diabetes Management
Health Informatics

Background:

The proliferation of connected health devices, including glucose monitors, smart insulin pens, and fitness trackers, presents opportunities for data-driven healthcare.
Patient and healthcare provider interest in virtual care and remote monitoring is increasing due to evolving payment and practice models.

Purpose of the Study:

To explore the potential of connected devices in creating a data-driven clinical practice model with remote monitoring capabilities.
To use diabetes as a case study and smart insulin pens as a specific use case to illustrate this approach.

Main Methods:

Defining the category and characteristics of smart insulin pens.
Describing the key features of a data-driven practice model.
Outlining the steps for integrating smart insulin pen remote monitoring into diabetes care for injection therapy patients.

Main Results:

Connected devices facilitate remote patient monitoring and virtual care delivery.
Smart insulin pens offer a specific use case for data-driven diabetes management.
The integration of these technologies can enhance diabetes care for patients on injection therapy.

Conclusions:

A data-driven clinical practice model incorporating remote monitoring via smart insulin pens is feasible and beneficial for diabetes care.
This approach supports the evolution towards virtual care and personalized medicine.
Further implementation of smart insulin pen technology can improve patient outcomes and healthcare efficiency.